Lung Tensioning Device Coil Treatment in Patients with Severe Emphysema: A Prospective Safety and Feasibility Trial (EFFORT)

医学 肺 随机对照试验 外科 前瞻性队列研究 肺气肿 重症监护医学 麻醉 内科学
作者
Sharyn A. Roodenburg,Karin Klooster,Jorine E. Hartman,Konstantina Kontogianni,Judith Brock,A. Susanne Dittrich,Marlies van Dijk,T. David Koster,Felix Herth,Dirk‐Jan Slebos
出处
期刊:Respiration [Karger Publishers]
卷期号:104 (1): 1-11 被引量:3
标识
DOI:10.1159/000541366
摘要

Introduction: Currently, there is a lack of bronchoscopic lung volume reduction options that do not depend on fissure integrity. Endobronchial coils have been extensively studied to address this need but exhibited variable patient response and have been discontinued. Lung tension device (LTD) coils represent the next-generation coil treatment. This study aimed to evaluate safety, feasibility, and efficacy of LTD-coil treatment. Methods: Patients with advanced emphysema and hyperinflation were enrolled at two European sites. LTD-coils (Free Flow Medical, Fremont, CA, USA) were implanted in the two most destructed lobes, as determined by quantitative CT analysis, in two separate procedures. The primary endpoint was 3-month follow-up after the last treatment. Results: Fourteen patients (50% male, median age 64 years, FEV<sub>1</sub> 23%predicted, RV 249%predicted) received LTD-coil treatment: 12 received bilateral and 2 unilateral treatment. Six serious respiratory adverse events occurred within the initial 3 months posttreatment, including one device-associated death. Treatment significantly reduced in- and expiratory volume of the treated lobes (−410 [−710, −340], p = 0.004 and −650 [−730, −190] mL, p < 0.001, respectively) and improved quality of life (SGRQ total score −4.6 [−21.0, −2.6], p < 0.001). However, at a group level, no significant improvements in pulmonary function or 6-min walk distance were observed. Responder rates ranged from 18% to 54% for the different endpoints. Conclusion: This first-in-human study shows that the new LTD-coil procedure is feasible with a safety profile comparable to the previous coil treatment. While the treatment effectively reduced lobar volume and modestly improved quality of life up to 3 months’ follow-up, at a group level it did not significantly enhance pulmonary function or exercise capacity.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
尼卡地平完成签到 ,获得积分10
刚刚
99668完成签到,获得积分10
2秒前
小时发布了新的文献求助20
2秒前
彼翎完成签到,获得积分10
2秒前
朴实归尘发布了新的文献求助10
3秒前
li完成签到 ,获得积分10
3秒前
3秒前
4秒前
4秒前
倔强小沐完成签到,获得积分10
5秒前
5秒前
41完成签到,获得积分10
5秒前
生菜发布了新的文献求助10
7秒前
彩色以彤完成签到 ,获得积分10
7秒前
吴xl发布了新的文献求助10
8秒前
8秒前
老百姓完成签到 ,获得积分10
10秒前
周周发布了新的文献求助10
11秒前
11秒前
小张同学发布了新的文献求助10
12秒前
shizhiheng完成签到 ,获得积分10
12秒前
1101592875的应助被Darcy采纳,获得10
12秒前
英勇皮皮虾完成签到,获得积分10
12秒前
苹果海云完成签到 ,获得积分10
13秒前
yi的应助被蓝包蛋采纳,获得10
13秒前
sxw完成签到 ,获得积分10
14秒前
啦啦啦完成签到,获得积分10
15秒前
daning完成签到,获得积分10
15秒前
完美世界的应助被景行采纳,获得10
15秒前
杨一一完成签到 ,获得积分10
15秒前
令狐大侠发布了新的文献求助30
17秒前
FashionBoy的应助被零一采纳,获得10
17秒前
情怀的应助被科研通管家采纳,获得10
17秒前
渡人舟的应助被科研通管家采纳,获得30
18秒前
所所的应助被科研通管家采纳,获得10
18秒前
18秒前
child完成签到,获得积分10
18秒前
Ava的应助被科研通管家采纳,获得10
18秒前
Ryo的应助被科研通管家采纳,获得10
18秒前
香蕉觅云的应助被科研通管家采纳,获得10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185743
求助须知:如何正确求助?哪些是违规求助? 9574397
关于积分的说明 21836038
捐赠科研通 7783520
什么是DOI,文献DOI怎么找? 3434643
关于科研通互助平台的介绍 2559017
邀请新用户注册赠送积分活动 2481440